Saudi Edition

Sections

Business
Regulation
Gigaprojects
Companies
Industries
Regions
Newsmakers
Explainers
Data
Archives
Lifestyle
Calendar

About

About EnterpriseAM
Advertise with us
Contact Us
Get advice from us
Work with us
Our newsletters

Privacy & Support

Privacy Policy

Search for:

Business
Regulation
Gigaprojects
Companies
Industries
Regions
Newsmakers
Explainers
Data
Archives
Lifestyle
Calendar

Skip to content

Saudi Edition

KSA

Search

Business
Regulation
Gigaprojects
Companies
Industries
Regions
Newsmakers
Explainers
Data
Archives
Lifestyle
Calendar

Get EnterpriseAM daily

(required)

Δ

Aja Pharma

Home / Aja Pharma

Jamjoom wants to make a type 2 diabetes drug in Saudi amid deeper push into localization

Jamjoom wants to make a type 2 diabetes drug in Saudi amid deeper push into localization

The contract runs until January 2026

Search

More From Enterprise

IPO

THIS MORNING: IPO ambitions hold steady against valuation markdowns as June deadlines loom

THIS MORNING: IPO ambitions hold steady against valuation markdowns as June deadlines loom

M&A

Savvy to snap up ByteDance’s Moonton for USD 6 bn?

Savvy to snap up ByteDance’s Moonton for USD 6 bn?

Debt

The regional war hits the international bond market

The regional war hits the international bond market

Business leaders spend their mornings with us.

Get EnterpriseAM — the daily newsletter now available in English and Arabic formats.

Get EnterpriseAM daily

The Roundup of news and trends that move your markets and shape corporate agendas delivered straight to your inbox.

EnterpriseAM is an independent publication owned by Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 136994), under license from AJP Media. The content provided in publications produced by EnterpriseAM is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of third party reporting contained in this publication, whether in the form of summaries or analysis.

About

About EnterpriseAM
Advertise with us
Contact Us
Get advice from us
Work with us
Our newsletters

Privacy & Support

Privacy Policy

My EnterpriseAM

Sign in

© 2026 Enterprise Ventures LLC View important tax notices.

EnterpriseAM is available without charge thanks to the generous support of our advertisers.

Queue

Now Playing

Now Playing

00:00

00:00

Sign in

Email address Terms of Service

Check your email! We've sent you a magic link to sign in.